Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

por Bandari, Daniel S., Sternaman, Debora, Chan, Theodore, Prostko, Chris R., Sapir, Tamar
Publicado 2012

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter...

por Singer, Barry, Bandari, Daniel, Cascione, Mark, LaGanke, Christopher, Huddlestone, John, Bennett, Randy, Dangond, Fernando
Publicado 2012

High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study

por Francisco, Gerard E., Bandari, Daniel S., Bavikatte, Ganesh, Jost, Wolfgang H., McCusker, Emily, Largent, Joan, Zuzek, Aleksej, Esquenazi, Alberto
Publicado 2020

Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE...

por Francisco, Gerard E., Jost, Wolfgang H., Bavikatte, Ganesh, Bandari, Daniel S., Tang, Simon F.T., Munin, Michael C., Largent, Joan, Adams, Aubrey M., Zuzek, Aleksej, Esquenazi, Alberto
Publicado 2020

Long‐Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity

por Esquenazi, Alberto, Bavikatte, Ganesh, Bandari, Daniel S., Jost, Wolfgang H., Munin, Michael C., Tang, Simon Fuk Tan, Largent, Joan, Adams, Aubrey Manack, Zuzek, Aleksej, Francisco, Gerard E.
Publicado 2021

Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis

por Buckle, Guy, Bandari, Daniel, Greenstein, Jeffrey, Gudesblatt, Mark, Khatri, Bhupendra, Kita, Mariko, Repovic, Pavle, Riser, Emily, Weinstock-Guttman, Bianca, Thrower, Ben, Loring, Sherrill, Riester, Katherine, Everage, Nick, Prada, Claudia, Koulinska, Irene, Mann, Monica
Publicado 2020